1. Ability to provide written informed consent (by the parents or legally acceptable/authorized representative (LAR) and assent by the children (verbal/oral assent for the children of age between 7-12 years, and written assent for the children of age between >12 to 18 years), and Audio video consent for all participants. <br/ >2. Participants of either gender of age between â?¥2 to â?¤18years (Participant should be â?¤18 years at the time of Screening of the study). <br/ >3. Good general health as determined by the discretion of investigator. <br/ >4. Expressed interest and availability to fulfill the study requirements. <br/ >5. Agrees not to participate in another clinical trial at any time during the study period. <br/ >6. Agrees to remain in the study area for the entire duration of the study. <br/ >7. Willing to allow storage and future use of biological samples for future research <br/ >

1. Ability to provide written informed consent (by the parents or legally acceptable/authorized representative (LAR) and assent by the children (verbal/oral assent for the children of age between 7-12 years, and written assent for the children of age between >12 to 18 years), and Audio video consent for all participants. <br/ >2. Participants of either gender of age between â?¥2 to â?¤18years (Participant should be â?¤18 years at the time of Screening of the study). <br/ >3. Good general health as determined by the discretion of investigator. <br/ >4. Expressed interest and availability to fulfill the study requirements. <br/ >5. Agrees not to participate in another clinical trial at any time during the study period. <br/ >6. Agrees to remain in the study area for the entire duration of the study. <br/ >7. Willing to allow storage and future use of biological samples for future research <br/ >

1. Ability to provide written informed consent (by the parents or legally acceptable/authorized representative (LAR) and assent by the children (verbal/oral assent for the children of age between 7-12 years, and written assent for the children of age between >12 to 18 years), and Audio video consent for all participants. <br/ >2. Participants of either gender of age between â?¥2 to â?¤18years (Participant should be â?¤18 years at the time of Screening of the study). <br/ >3. Good general health as determined by the discretion of investigator. <br/ >4. Expressed interest and availability to fulfill the study requirements. <br/ >5. Agrees not to participate in another clinical trial at any time during the study period. <br/ >6. Agrees to remain in the study area for the entire duration of the study. <br/ >7. Willing to allow storage and future use of biological samples for future research <br/ >

1. Ability to provide written informed consent (by the parents or legally acceptable/authorized representative (LAR) and assent by the children (verbal/oral assent for the children of age between 7-12 years, and written assent for the children of age between >12 to 18 years), and Audio video consent for all participants. <br/ >2. Participants of either gender of age between â?¥2 to â?¤18years (Participant should be â?¤18 years at the time of Screening of the study). <br/ >3. Good general health as determined by the discretion of investigator. <br/ >4. Expressed interest and availability to fulfill the study requirements. <br/ >5. Agrees not to participate in another clinical trial at any time during the study period. <br/ >6. Agrees to remain in the study area for the entire duration of the study. <br/ >7. Willing to allow storage and future use of biological samples for future research <br/ >